0000899243-21-042078.txt : 20211029 0000899243-21-042078.hdr.sgml : 20211029 20211029192301 ACCESSION NUMBER: 0000899243-21-042078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211028 FILED AS OF DATE: 20211029 DATE AS OF CHANGE: 20211029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Primiano Christopher Brett CENTRAL INDEX KEY: 0001603510 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40971 FILM NUMBER: 211364817 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS INC. STREET 2: 85 WELLS AVENUE, SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aura Biosciences, Inc. CENTRAL INDEX KEY: 0001501796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 320271970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617)500-8864 MAIL ADDRESS: STREET 1: 85 BOLTON STREET CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-28 0 0001501796 Aura Biosciences, Inc. AURA 0001603510 Primiano Christopher Brett C/O AURA BIOSCIENCES, INC. 85 BOLTON STREET CAMBRIDGE MA 02140 0 1 0 0 Chief Business Officer Common Stock 2021-10-28 4 A 0 8750 0.00 A 8750 D Stock Option (Right to Buy) 14.00 2021-10-28 4 A 0 37500 A 2031-10-27 Common Stock 37500 37500 D These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant. The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2022 with the remainder vesting thereafter in annual installments. /s/ Julie Feder 2021-10-29